CIAS
EDIT icon

Capital Investment Advisory Services’s Editas Medicine EDIT Stock Holding History

Capital Investment Advisory Services’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,200
Closed -$27K – 746
2019
Q3 		$27K Buy
1,200
+200
+20% +$4.95K 0.01% 724
2019
Q2 		$25K Buy
+1,000
New +$23.9K 0.01% 724

Other funds holding EDIT

NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Capital Investment Advisory Services's EDIT Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Editas Medicine (EDIT) in Q4 2019, closing a stake of 1,200 shares — an estimated $27K sold.

Capital Investment Advisory Services first reported a position in EDIT in Q2 2019 and held it in 2 quarters. The position peaked at $27K in Q3 2019. 229 funds tracked by Wall St. Rank hold EDIT as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Editas Medicine position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 1,200 Editas Medicine shares in Q4 2019, an estimated $27K.
  • Capital Investment Advisory Services first reported a position in Editas Medicine in Q2 2019 and held it in 2 quarters.
  • Capital Investment Advisory Services's Editas Medicine position peaked at $27K in Q3 2019.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.